Comparable stake leader
Harel Insurance Investments & Financial Services Ltd.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000818686.
Comparable stake leader
Harel Insurance Investments & Financial Services Ltd.
Disclosed value leader
Harel Insurance Investments & Financial Services Ltd.
Comparable rows
5/50
Latest evidence
05 Nov 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
5 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. |
13D/G
|
6%
Reported 13D/G
· 30 Sep 2026
|
$2,899,117,335
70,418,201 shares
|
-$78,525,764 | 30 Sep 2026 |
| Migdal Insurance & Financial Holdings Ltd. |
13D/G
13F
Company
|
5.4%
Reported 13D/G
· 31 Dec 2025
|
$2,022,794,213
61,689,363 shares
|
$0 | 31 Dec 2025 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13D/G
|
5%
Reported 13D/G
· 05 Nov 2026
|
$2,305,097,824
58,209,541 shares
|
+$32,248,973 | 05 Nov 2026 |
| Phoenix Financial Ltd. |
13D/G
13F
Company
|
4.8%
Reported 13D/G
· 04 Nov 2026
|
$2,328,169,625
56,550,149 shares
|
$0 | 04 Nov 2026 |
| FMR LLC |
13D/G
|
2.1%
Reported 13D/G
· 30 Sep 2025
|
—
24,641,361 shares
|
-$561,363,714 | 30 Sep 2025 |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$1,682,110,760
42,253,473 shares
|
— | 30 Sep 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$1,291,590,182
32,515,751 shares
|
— | 30 Sep 2026 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$764,640,598
19,309,106 shares
|
— | 30 Sep 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$125,649,337.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 814,064 | $0 | $33,242,786 | -$33,242,786 |
| 3-6 | 0 | 195,922 | $0 | $6,718,825 | -$6,718,825 |
| 6-9 | 0 | 1,688,031 | $0 | $56,107,868 | -$56,107,868 |
| 9-12 | 0 | 948,067 | $0 | $29,579,857 | -$29,579,857 |
Reporting owners
Showing 1-20 of 38 reporting-owner rows connected to TEVA PHARMACEUTICAL INDUSTRIES LTD. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Amir Elstein | Director | $63,807,864 | Mixed | 05 Jun 2026 | ||
| Richard D. Francis | President and CEO | $39,175,764 | -$41,822,264 | -52% | Filing P/S | 10 Nov 2026 |
| Kare Schultz | President and CEO, Director | $15,013,641 | Mixed | 01 Nov 2022 | ||
| Sol J. Barer | Director | $13,494,091 | Mixed | 05 Jun 2026 | ||
| Eric A. Hughes | Executive Vice President, Global R&D and Chief Medical Officer. | $4,703,929 | -$4,173,498 | -47% | Filing P/S | 03 Aug 2026 |
| Ronit Satchi-Fainaro | Director | $4,171,478 | -$15,459 | -0.37% | Filing P/S | 21 Aug 2026 |
| Roberto A. Mignone | Director | $4,059,061 | -$17,998,952 | -82% | Mixed | 19 Sep 2026 |
| Gerald M. Lieberman | Director | $3,920,087 | Mixed | 05 Jun 2026 | ||
| Rosemary A. Crane | Director | $3,847,498 | Mixed | 05 Jun 2026 | ||
| Perry D. Nisen | Director | $3,608,586 | Mixed | 05 Jun 2026 | ||
| Mark Sabag | Executive Vice President, International Markets Commercial | $3,564,827 | -$17,049,962 | -83% | Filing P/S | 12 Nov 2026 |
| Tal Zvi Zaks | Director | $2,553,793 | -$593 | -0.02% | Filing P/S | 05 Aug 2026 |
| Richard Daniell | EVP, Europe Commercial | $2,386,386 | -$14,007,234 | -85% | Filing P/S | 09 Nov 2026 |
| Christine Fox | EVP, U.S. Commercial | $2,247,375 | -$1,996,445 | -47% | Filing P/S | 30 Apr 2026 |
| Eliyahu Sharon Kalif | EVP, Chief Financial Officer | $2,237,374 | -$20,725,392 | -90% | Filing P/S | 11 Jun 2026 |
| Eric Drape | Executive VP Global Operations | $1,972,100 | Mixed | 05 Mar 2024 | ||
| Sven Dethlefs | EVP, North America Commercial | $1,609,736 | Mixed | 06 Mar 2023 | ||
| Janet S. Vergis | Director | $1,254,345 | Mixed | 05 Jun 2025 | ||
| Evan Lippman | EVP, Business Development | $935,985 | -$2,162,658 | -70% | Filing P/S | 17 Aug 2026 |
| Dov Bergwerk | Interim Chief Legal Officer | $804,394 | -$1,095,567 | -58% | Median | 15 Nov 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Dov Bergwerk | TEVA | Ordinary Shares | Options Exercise | 70.1% | 8,370 | 20,313 | 15 Nov 2026 | Direct | ||
| Dov Bergwerk | TEVA | Restricted Share Units | Options Exercise | -50% | -8,370 | 8,372 | 15 Nov 2026 | Direct | ||
| Mark Sabag | TEVA | Ordinary Shares | Sale | -35.6% | -$1,973,544 | $44.14 | -44,710 | 80,760 | 12 Nov 2026 | Direct |
| Mark Sabag | TEVA | Ordinary Shares | Options Exercise | 55.4% | 44,710 | 125,470 | 12 Nov 2026 | Direct | ||
| Mark Sabag | TEVA | Stock Options (right to buy) | Options Exercise | -100% | -44,710 | 0 | 12 Nov 2026 | Direct | ||
| Richard Daniell | TEVA | Ordinary Shares | Sale | -26.4% | -$856,154 | $42.80 | -20,003 | 55,755 | 11 Nov 2026 | Direct |
| Richard Daniell | TEVA | Ordinary Shares | Options Exercise | 35.9% | 20,003 | 75,758 | 11 Nov 2026 | Direct | ||
| Richard Daniell | TEVA | Stock Options (right to buy) | Options Exercise | -100% | -20,003 | 0 | 11 Nov 2026 | Direct | ||
| Richard D. Francis | TEVA | Ordinary Shares | Sale | -21.2% | -$10,559,175 | $42.24 | -250,000 | 927,529 | 10 Nov 2026 | Direct |
| Dov Bergwerk | TEVA | Restricted Share Units | Award | 9,433 | 9,433 | 10 Nov 2026 | Direct | |||
| David J. Brailer | TEVA | Restricted Share Units | Award | 3,326 | 3,326 | 10 Nov 2026 | Direct | |||
| Richard Daniell | TEVA | Ordinary Shares | Sale | -31% | -$1,072,790 | $42.91 | -25,000 | 55,755 | 09 Nov 2026 | Direct |
| Richard Daniell | TEVA | Ordinary Shares | Options Exercise | 44.8% | 25,000 | 80,755 | 09 Nov 2026 | Direct | ||
| Richard Daniell | TEVA | Stock Options (right to buy) | Options Exercise | -55.6% | -25,000 | 20,003 | 09 Nov 2026 | Direct | ||
| Amir Weiss | TEVA | Ordinary Shares | Sale | -83% | -$744,049 | $43.04 | -17,289 | 3,537 | 09 Nov 2026 | Direct |
| Amir Weiss | TEVA | Ordinary Shares | Options Exercise | 59.3% | 7,755 | 20,826 | 09 Nov 2026 | Direct | ||
| Amir Weiss | TEVA | Stock Options (right to buy) | Options Exercise | -100% | -7,755 | 0 | 09 Nov 2026 | Direct | ||
| Mark Sabag | TEVA | Ordinary Shares | Sale | -36.3% | -$1,928,729 | $41.93 | -46,000 | 80,760 | 05 Nov 2026 | Direct |
| Mark Sabag | TEVA | Ordinary Shares | Options Exercise | 57% | 46,000 | 126,760 | 05 Nov 2026 | Direct | ||
| Mark Sabag | TEVA | Stock Options (right to buy) | Options Exercise | -50.7% | -46,000 | 44,710 | 05 Nov 2026 | Direct | ||
| Dov Bergwerk | TEVA | Ordinary Shares | Sale | -68.7% | -$1,095,567 | $41.72 | -26,260 | 11,943 | 04 Nov 2026 | Direct |
| Dov Bergwerk | TEVA | Ordinary Shares | Options Exercise | 823.7% | 26,260 | 29,448 | 04 Nov 2026 | Direct | ||
| Dov Bergwerk | TEVA | Stock Options (right to buy) | Options Exercise | -100% | -26,260 | 0 | 04 Nov 2026 | Direct | ||
| Brian P. Savage | TEVA | Ordinary Shares | Sale | -46.4% | -$285,215 | $38.85 | -7,342 | 8,500 | 18 Sep 2026 | Direct |
| Brian P. Savage | TEVA | Ordinary Shares | Options Exercise | 39.7% | 4,503 | 15,842 | 18 Sep 2026 | Direct | ||
| Brian P. Savage | TEVA | Stock Options (right to buy) | Options Exercise | -100% | -4,503 | 0 | 18 Sep 2026 | Direct | ||
| Roberto Mignone | TEVA | Ordinary Shares | Sale | -100% | -$14,356,802 | $39.06 | -367,600 | 0 | 18 Sep 2026 | [see footnote] |
| Amir Weiss | TEVA | Ordinary Shares | Options Exercise | 19.1% | 2,500 | 15,571 | 21 Aug 2026 | Direct | ||
| Amir Weiss | TEVA | Ordinary Shares | Sale | -42% | -$355,301 | $37.62 | -9,445 | 13,071 | 21 Aug 2026 | Direct |
| Amir Weiss | TEVA | Stock Options (right to buy) | Options Exercise | -25% | -2,500 | 7,502 | 21 Aug 2026 | Direct | ||
| Ronit Satchi-Fainaro | TEVA | Ordinary Shares | Sale | -0.37% | -$15,459 | $37.25 | -415 | 111,986 | 21 Aug 2026 | Direct |
| Evan Lippman | TEVA | Ordinary Shares | Sale | -42.1% | -$680,291 | $36.57 | -18,600 | 25,591 | 17 Aug 2026 | Direct |
| Tal Zvi Zaks | TEVA | Ordinary Shares | Sale | -0.02% | -$593 | $34.87 | -17 | 73,247 | 05 Aug 2026 | Direct |
| Placid Jover | TEVA | Ordinary Shares | Sale | -65.4% | -$447,351 | $34.88 | -12,827 | 6,774 | 03 Aug 2026 | Direct |
| Placid Jover | TEVA | Ordinary Shares | Options Exercise | 189.4% | 12,827 | 19,601 | 03 Aug 2026 | Direct | ||
| Placid Jover | TEVA | Restricted Share Units | Options Exercise | -33.3% | -12,827 | 25,657 | 03 Aug 2026 | Direct | ||
| Eric A. Hughes | TEVA | Ordinary Shares | Sale | -15.9% | -$892,051 | $34.88 | -25,578 | 134,877 | 03 Aug 2026 | Direct |
| Eric A. Hughes | TEVA | Ordinary Shares | Options Exercise | 49% | 52,744 | 160,455 | 03 Aug 2026 | Direct | ||
| Eric A. Hughes | TEVA | Restricted Share Units | Options Exercise | -100% | -52,744 | 0 | 03 Aug 2026 | Direct | ||
| Matthew Shields | TEVA | Ordinary Shares | Sale | -100% | -$321,547 | $32.19 | -9,989 | 0 | 18 Jun 2026 | Direct |
| Eliyahu Sharon Kalif | TEVA | Ordinary Shares | Sale | -61.9% | -$3,633,308 | $34.10 | -106,563 | 65,621 | 11 Jun 2026 | Direct |
| Sol J. Barer | TEVA | Ordinary Shares | Options Exercise | 5.1% | 21,739 | 448,011 | 05 Jun 2026 | Direct | ||
| Sol J. Barer | TEVA | Restricted Share Units | Options Exercise | -100% | -21,739 | 0 | 05 Jun 2026 | Direct | ||
| Chen Lichtenstein | TEVA | Ordinary Shares | Options Exercise | 301.7% | 14,492 | 19,296 | 05 Jun 2026 | Direct | ||
| Chen Lichtenstein | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Rosemary A. Crane | TEVA | Ordinary Shares | Options Exercise | 12.8% | 14,492 | 127,739 | 05 Jun 2026 | Direct | ||
| Rosemary A. Crane | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Amir Elstein | TEVA | Ordinary Shares | Options Exercise | 0.69% | 14,492 | 2,118,455 | 05 Jun 2026 | Direct | ||
| Amir Elstein | TEVA | Restricted Share Units | Options Exercise | -100% | -14,492 | 0 | 05 Jun 2026 | Direct | ||
| Gerald M. Lieberman | TEVA | Ordinary Shares | Options Exercise | 12.5% | 14,492 | 130,149 | 05 Jun 2026 | Direct |